Takeda picks first woman as CEO of centuries-old drugmaker
Julie Kim has been running Takeda’s US operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval.
The Harvard Crimson3d
BioMed Realty Acquires Three New Buildings in Kendall Square
BioMed Realty, one of the biggest labspace owners in the Boston area, recently acquired 215 First St., 150 Second St. and 11 ...
The Boston Globe9d
Crews building new Takeda tower in Cambridge celebrate a milestone, in frigid temps
Bone-chilling temperatures couldn’t keep the crowds away from Takeda’s Kendall Square campus ... commercial projects underway in Greater Boston right now. (Stubbornly high borrowing costs ...
BioPharma Dive1d
Christophe Weber, veteran Takeda CEO, to retire next year
Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.